Announcement PDF 20 July 2017 Company Announcements Office Australian Securities Exchange 20 Bridge Street SYDNEY NSW 2000 Dear Sir/Madam NOTICE UNDER SECTION 708A OF THE CORPORATIONS ACT This notice is given by Race Oncology Limited pursuant to section 708A(5)(e) of the Corporations Act (Act). The Company has today issued 11,250,000 fully paid ordinary shares at an issue price of $0.20 per share (Shares) in accordance with the terms of share placement announced to the market on 17 July 2017. Pursuant to section 708A(5)(e) of the Act, the Company gives notice that: 1. the Company issued the Shares without disclosure to investors under part 6D.2 of the Act; 2. as at the date of this notice, the Company has complied with: (a) the provisions of Chapter 2M of the Act as they apply to the Company; and (b) section 674 of the Act; and 3. as at the date of this notice, there is no information that is “excluded information” (as defined in section 708A(7) of the Act) which is required to be disclosed by the Company. Yours faithfully Peter Webse Company Secretary Race Oncology Limited, ABN 61 149 318 749 Level 2, 50 Kings Park Road, West Perth WA 6005 www.raceoncology.com